Adimab

Antibody Discovery And Engineering Platform

Lebanon, United States · Founded 2007 · $26.0M raised

Employees
51–200
Founded
2007
Business Model
B2B
Website
adimab.com
Total Funding
$26.0M
Last Round
$13.8M Series FJan 2012
Rounds
6

About

Provides antibody discovery and engineering services to biopharma partners using a yeast-based platform to deliver therapeutic antibodies and protein modalities.

Summary

Adimab is an Antibody Discovery company based in Lebanon, United States, founded in 2007. It has raised $26.0M in total across 6 rounds, most recently a $13.8M Series F round in Jan 2012. Investors include GV, Polaris Capital and SV Life Sciences.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series FSeries FJan 2012
$13.8M

Sign up to see all 6 rounds

Series A through Series F — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adimab on Indexed.vc
<a href="https://indexed.vc/companies/adimab"><img src="https://indexed.vc/api/badge/company/adimab" alt="Adimab on Indexed.vc" width="260" height="76" /></a>